Legal & General Group
AYTU icon

Legal & General Group’s AYTU BioPharma AYTU Stock Holding History

Legal & General Group’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-88
Closed -$13K – 3493
2021
Q1 		$13K Buy
88
+74
+529% +$11.7K ﹤0.01% 3294
2020
Q4 		$2K Hold
14
– – ﹤0.01% 3471
2020
Q3 		$3K Hold
14
– – ﹤0.01% 3410
2020
Q2 		$4K Buy
+14
New +$4.24K ﹤0.01% 3386

Other funds holding AYTU

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Legal & General Group's AYTU Position: Q2 2021 in Review

Legal & General Group sold out of AYTU BioPharma (AYTU) in Q2 2021, closing a stake of 88 shares — an estimated $13K sold.

Legal & General Group first reported a position in AYTU in Q2 2020 and held it in 4 quarters. The position peaked at $13K in Q1 2021. 50 funds tracked by Wall St. Rank hold AYTU as of Q2 2021.

  • Legal & General Group reported no remaining AYTU BioPharma position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 88 AYTU BioPharma shares in Q2 2021, an estimated $13K.
  • Legal & General Group first reported a position in AYTU BioPharma in Q2 2020 and held it in 4 quarters.
  • Legal & General Group's AYTU BioPharma position peaked at $13K in Q1 2021.
  • 50 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.